Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation

Blood

Volumn 96, Issue 8, 2000, Pages 2814-2821

  Marshall, N A ^a   Howe, J G ^a   Formica, R ^a   Krause, D ^a   Wagner, J E ^a   Berliner, N ^a   Crouch, J ^a   Pilip, I ^a   Cooper, D ^a   Blazar, B R ^a   Seropian, S ^a   Pamer, E G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ALLOTRANSPLANTATION; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; UMBILICAL CORD BLOOD; VIREMIA;

EID: 0034667535     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.8.2814.h8002814_2814_2821     Document Type: Article

References (42)

1. Bone marrow transplantation for therapy in autoimmune disease
2. Stem cell transplantation for severe autoimmune diseases: Progress and problems
3. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors
4. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia
5. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection
6. Current use of polyclonal antilymphocyte antibody preparations
7. Biology and adoptive cell therapy of Epstein-Barr virus associated lymphoproliferative disorders in recipients of marrow allografts
8. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
9. Immunodeficiency-associated lymphoproliferative disorders
10. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
11. Infusions of donor leukocytes to treat Epstein-Barr virus associated lymphoproliferative disorders after allogeneic bone marrow transplantation
12. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
13. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
14. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
15. Evolution of a complex TCR repertoire during primary and recall bacterial infection
16. Analysis of Gag-specific cytotoxic T lymphocytes in Simian Immunodeficiency Virus-infected rhesus monkeys by cell staining with tetrameric major histocompatibility complex class I-peptide complex
17. Phenotypic analysis of antigen specific T lymphocytes
18. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
19. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
20. Coordinate regulation of complex T cell populations responding to bacterial infection
21. H2-M3 restricted T cells in bacterial infection: Rapid primary but diminished memory responses
22. Detection of Epstein Barr virus in the brain by the polymerase chain reaction
23. A high-sensitivity electrochemiluminescence-based detection system for automated PCR product quantification
24. Immunodominant and subdominant CTL responses to Listeria monocytogenes infection
25. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4
26. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides
27. T cell affinity maturation by selective expansion following infection
28. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time
29. Natural variants of the immunodominant HLAA11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I: Peptide complexes
30. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children
31. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
32. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation
33. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia
34. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation
35. Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients
36. Allogeneic blood stem cell transplantation: Peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34 + Thy-1 Dim CD38-) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease
37. The use of mobilized peripheral blood stem cells from normal donors for allografting
38. A new look at T cells
39. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients
40. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
41. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: Prophylactic infusion of EBV-specific cytotoxic T cells